Adverse events include fever, chills, tremors and headache,and there is one death associated with the use of these products.
Il Comitato di Valutazione del Rischio per la Farmacovigilanza dell’EMA (PRAC) ritiene basso il rischio di gravi reazioni allergiche con i medicinali contenenti ambroxol e bromexina.
Pregnant women urged to discuss all medicines with their health care professionals before using them.
Inhalation of a non-sterile product with microbial contamination into the airways could increase the risk of respiratory infection.
80.211.154.110